Upon encounter with antigen, CD4
Introduction

Specific CD4
+ T cell effector responses can be delegated to distinct subsets characterized as T h 1, T h 2, T h 17 or regulatory T cell (Treg) cells, with the development of each of these subsets being driven, respectively, by the master lineage-specific transcription factors T-bet [now also denoted as T-box 21 (TBX21)], GATA binding protein 3 (GATA-3), retinoid-related orphan receptor ct (RORct) or forkhead box protein P3 (FOXP3) (1). T-cell-dependent antibody production is a critical component of the normal immune response, and T h 2 cells were originally believed to be the predominant source of B cell help because of their production of IL-4, a cytokine known to be involved in B cell proliferation as well as Ig class switching (1).
Subsequently, IL-21 was identified as a T h -derived, type I, four-a-helical bundle cytokine that was critical for plasma cell generation as well as isotype switching (2) and normal Ig production (3), consistent with IL-21 being a T h 2-specific cytokine (4); however, other data indicated that IL-21 had T h 1-like properties as well (5).
More recently it became clear that the CD4 + T cells involved in germinal center (GC) formation and function-denoted T follicular helper cells (T FH cells)-were distinct from any of these previously identified subsets. These T FH cells expressed high levels of the chemokine receptor CXCR5 [chemokine (C-X-C motif) receptor 5], allowing them to home to and be retained by the lymphoid follicle, where contact with antigen-primed B cells led to B cell proliferation, isotype switching and somatic mutation of the Ig repertoire (6, 7) . Gene microarray analysis revealed that follicle-localized CXCR5 + T h cells had a very distinctive transcriptional profile that distinguished these cells from T h 1 or T h 2 cells, with highlevel IL-21 and B-cell CLL lymphoma-6 (BCL6) messenger RNAs (mRNAs) (5), both of which are now considered hallmarks of T FH cells (6) .
IL-21 is a type I cytokine that signals via a specific receptor protein, IL-21R (8, 9) , and the common cytokine receptor c chain, c c , which is shared by the receptors for IL-2, IL-4, IL-7, IL-9, IL-15 and IL-21 (10); c c is mutated in humans with X-linked SCID (11) . IL-21 signals in part via STAT3 (signal transducer and activator of transcription 3) (12) , with actions on a wide range of lineages, including T cells, B cells, NK cells and dendritic cells (10) . Specifically, IL-21 can promote the expansion of CD8 + T cells, is critical for normal Ig production by B cells, can inhibit dendritic cell function and, interestingly, can be pro-apoptotic for B cells and NK cells (10) . Whereas IL-21 was first identified as a cytokine produced by activated peripheral blood T cells (9) , it is now known that it can be produced by a range of differentiated T h populations (10) as well as by NKT cells (13) .
In this review, we discuss the role of IL-21 in the generation of T FH cells as well as in the functional interaction of these cells with B cells within the GC. The relationship between T FH and other T h subsets will also be discussed, as more evidence mounts in support of flexibility of cytokine profiles within the T FH cells. In addition, the role played by IL-21 in the interaction between the T FH master transcription factor BCL6 and other lineage-specific transcription factors will be discussed. Finally, elevated levels of IL-21 and T FHspecific surface molecules have been implicated in the development of systemic autoimmune responses, and the mechanisms for disease development will be addressed.
Identification of a T FH profile
Early molecular profiling of human T FH cells revealed that although a large number of transcripts were shared by T FH , T h 1 and T h 2 effector cells, a subset of genes were preferentially expressed by T FH cells, including those encoding CXCR5, IL-21, BCL6 and ICOS (inducible co-stimulatory molecule) (5). Although these genes were transiently expressed to some degree by activated T h 1 or T h 2 cells, the spatial and temporal expression pattern of these proteins in T FH cells was coincident with their functions. Interaction between CXCR5 and chemokine (C-X-C motif) ligand 13 (CXCL13), which is produced in the follicle, was required for the localization of T FH to the GC (14) , whereas ICOS costimulatory interactions with inducible co-stimulatory molecule ligand (ICOSL) on B cells were found to be important for GC development (15) . BCL6 was already known to be highly expressed within the GC and to be required for GC formation (16) . Finally, accumulating evidence has revealed that IL-21 is a key determinant of B-cell differentiation (2, 3, 10).
Both in vivo and in vitro evidence demonstrates that IL-21 is a T-cell-derived cytokine that is very important for B-cell proliferation and differentiation (10) . Mice that constitutively expressed IL-21 were found to have higher levels of plasma cells as well as higher levels of serum Igs (2). In vitro stimulation of both murine and human B cells with IL-21 induced the plasma-cell-associated transcription factor BLIMP1 (B-lymphocyte-induced maturation protein 1) [now termed PR domain containing 1, with ZNF domain (PRDM1)] and subsequent plasma cell differentiation as well as the accumulation of isotype-switched Igs (2, 17). Interestingly, Ozaki et al. also showed that IL-21 is a potent inducer of BCL6 (2), a transcription factor that negatively regulates expression of BLIMP1, just as BLIMP1 represses BCL6 (18), suggesting that these two transcription factors are induced in distinct populations of cells.
When a population of CXCR5 + tonsillar T FH cells was cultured with naive human B cells, the accumulation of Igsecreting B cells was decreased dramatically if IL-21 action was blocked, demonstrating that T FH secretion of IL-21 was critical for the differentiation of naive B cells (19) . Interestingly, in both murine and human in vitro systems, IL-4 was shown to antagonize the actions of IL-21 on plasma cell differentiation (2, 19) , even though analysis of Il21r or Il4 single-knockout (KO) mice and Il21r plus Il4 double-KO mice revealed that cooperative actions of these cytokines were required for Ig production (2). In addition, even though IL-21 is a potent inducer of IL-10 (20), IL-21 was found to be much more potent than IL-10 for the induction of Ig secretion from both naive and memory human B cells in vitro, suggesting that IL-21 plays a major role in both primary and memory responses to T-cell-dependent antigens (19) .
Although microarray analysis and hierarchical clustering revealed that the overall transcriptional profile of T FH cells was distinct from that of T h 17 cells as well as those of T h 1 or T h 2 cells (21) , both T FH and T h 17 subsets share highlevel expression of IL-21 (21) . IL-21 was found to be required in part for the in vitro differentiation of T h 17 cells, but it was not necessary for their in vivo differentiation (22) . These data suggested certain similarities but also important differences between T FH cells and T h 17 cells, worthy of further investigation.
IL-21 in the GC: B-cell versus T FH -cell action
GC development is impaired in mice deficient for IL-21 signaling (3). As producers of high levels of IL-21, T FH cells are important regulators of the GC reaction because of their close association with CXCR5 + B cells localized to the follicle that undergo differentiation in response to both soluble and cell-mediated signals and produce high-affinity Ig (6, 7) (Fig. 1) .
A recent study investigated whether this IL-21 requirement for the GC reaction reflected the action of IL-21 on either the B cells or the T FH cells (23) . Immunization of IL-21-KO mice with a T-cell-dependent antigen showed that CXCR5 surface expression on CD4 + T cells was greatly reduced in the absence of IL-21, suggesting that IL-21 has an autocrine role for proper T FH development. Consistent with this, IL-21R expression was significantly higher on CXCR5 +
CD4
+ than on 
cells (23). Adoptive transfer of wild-type (WT) CD4
+ T cells into Il21r-KO recipients followed by immunization rescued GC formation and partially rescued Ig production. However, the transfer of WT B cells into Il21r-KO mice could not rescue Ig production, indicating that the defect in these mice was intrinsic to the CD4 + T cells (23 (25) . T FH and T h 17 cells were also found to share high expression of the transcription factor c-Maf, and deletion of c-Maf led to reduced numbers of both T FH and T h 17 cells. This was related to the direct regulation of IL-21 transcription by c-Maf subsequent to the induction of c-Maf by ICOS-ICOSL interaction (25, 26) .
T FH cells producing alternative cytokines
Although it is clear that T FH cells are critical for directing the development of an antibody response by GC B cells, the above studies (21, 23) reported that IL-21 acts primarily in an autocrine manner on the T FH population, even though it is well known that IL-21 receptors are expressed on B cells and B cells can also respond to this cytokine by undergoing differentiation and producing Ig (2, 3, 10). Interestingly, gene microarray analysis suggested that T FH cells lacked expression of most cytokines or transcription factors associated with the T h 1, T h 2 or T h 17 subsets (5, 21), including IL-4 and IFN-c, making it unclear how and where these cytokines could influence B-cell Ig isotype switching if they were not produced by T FH cells. Importantly, however, in vitro T h activity for B-cell Ig production has also been detected in T h 1, T h 2 and T h 17 polarized populations, indicating that this helper activity is not specific only to T FH populations (27) .
Several reports have challenged the notion that T FH cells lack the expression of cytokines associated with these other T h subsets, including three studies that used infection with helminths that elicit strong T h 2 responses (28) (29) (30) .
The first study monitored IL-4 expression by employing a 'dual-reporter' mouse model in which IL-4 transcription and protein production could be distinguished. After infection with Schistosoma mansoni, the majority of IL-4-producing cells in lymph node and spleen expressed the T FH markers CXCR5, ICOS and programmed death-1 (PD-1), although the IL-4-producing cells within liver granulomas did not express these markers (28) . These IL-4-producing T FH cells expressed amounts of IL-4 and GATA-3 transcripts that were similar to the level found in T h 2 cells that did not express T FH markers and also produced the high levels of BCL6 characteristic of T FH 
cells. Experiments in which CXCR5
À PD-1 À cells that expressed green fluorescent protein-labeled IL-4 (this marks IL-4 protein in this dual-reporter system) were transferred into naive mice and then antigen challenged demonstrated that 20% of these cells could become CXCR5 + PD-1 + in vivo, confirming that at least a minority of T h 2 cells can develop into T FH cells (28) .
Consistent with this, the second study reported that IL-4-producing T FH cells were present in the mesenteric lymph nodes after infection with Heligmosomoides polygyrus. Using the IL-4 transcription/protein dual-reporter mice described above, CD4 + T cells that were committed to the T h 2 lineage were found throughout the follicle, but those T h 2 cells that produced IL-4 protein were found only near B cells in the GC region (29) . These IL-4 protein-producing cells expressed high levels of CXCR5, ICOS, PD-1, IL-21 and BCL6, as is typical of T FH cells.
The third study elegantly addressed the role of T FH cytokine production in isotype switching and somatic mutation. Here, conjugates consisting of B cells plus T cells were isolated from GCs of IL-4/IFNc dual-reporter mice that had been infected with Leishmania major (30) . These T cells expressed high levels of IL-21, BCL6 and CXCR5 characteristic of T FH cells. B-cell-T-cell conjugates with IL-4-expressing cells were shown to contain IgG1 transcripts, whereas conjugates that contained IFNc-expressing cells contained mainly IgG2a transcripts, demonstrating that the specific cytokine produced by the T FH was critical in the regulation of isotype switching in B cells. Purified IL-4-producing cells were analyzed for IL-21 production by enzyme-linked immunosorbent spot, and IL-4 + T FH cells from lymph nodes produced significantly higher amounts of IL-21 than did IL-4-producing cells from lungs. The IL-4-producing cells from the lungs but not the IL-4-producing T FH from the GC could function as classical T h 2 cells in that they could elicit eosinophil recruitment when transferred to IL-4-deficient mice, suggesting important differences between these populations (30) .
In addition to evidence supporting the existence of T FH cells expressing either IL-4 or IFNc, studies in mice prone to autoimmune lupus revealed the existence of T FH cells that produce both IL-17 and IL-21 (31) .
The most surprising example of lineage switching involves the conversion of FOXP3 + Treg cells to T FH cells in the Peyer's patches of the gut, where GCs are critical for the production of IgA (32) . When FOXP3 + cells were transferred into T-cell-deficient CD3e-KO mice, 80% of these were found to down-regulate FOXP3 expression, migrate into the B-cell follicles of Peyer's patches and express high levels of IL-21 and BCL6 (32) . Although FOXP3 down-regulation was not dependent on B cells as it could occur in B-cell-deficient mice, the acquisition of CXCR5, PD-1 and IL-21 required interaction with B cells in Peyer's patches (32) .
IL-21 in combination with transforming growth factor-b1 (TGFb1) produced by T FH cells can also contribute to the differentiation of IgA-secreting plasmablasts in the gut (33) . In this scenario, the combination of TGFb1 with IL-21 upregulated chemokine (C-C motif) receptor 10 (CCR10) and down-regulated CXCR5, thus allowing migration of the B cells out of the GC and toward the mucosal surface.
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Collectively, the above studies show that T FH cells can produce IL-4, IFNc or IL-17 and that these cells are potentially derived from a range of lineages, including T h 1, T h 2, T h 17 or Treg cells (Fig. 2) .
BCL6 as a master regulator of T FH cells
Although early gene expression analysis established a correlation between BCL6 transcription factor expression and T FH + T cells (34) . While over-expression of BCL6 was shown to up-regulate endogenous BCL6, IL-21R, IL6R and CXCR5 mRNA, it also inhibited IL-17 expression by blocking the functional activity of RORct without affecting RORct mRNA expression (34) . BCL6 over-expression also can inhibit the expression of T h 1-associated genes and T h 2-associated genes (34) . Experiments employing mixed bone marrow chimeras showed that BCL6 expression was required in both T and B cells for normal GC formation.
BCL6 repression of the development of other T h lineages involves direct binding and suppression of the promoters of the Tbx21 and Rorc genes in T FH cells (34) . BCL6 can also repress expression of microRNAs that otherwise suppress expression of T FH -specific genes such as those encoding CXCR5 and PD-1 (35) . Thus, over-expression of BCL6 led to a global down-regulation of microRNAs that targeted sites in the 3# untranslated regions of CXCR5 and PD-1 mRNAs, thereby promoting expression of the T FH program (35) .
Constitutive BCL6 expression induced expression of a panel of T FH markers but it also inhibited the expression of BLIMP1 (36), known to be an inhibitor of BCL6 function (18) . Over-expression of BLIMP1 in CD4 + T cells significantly reduced the number of T FH cells, without effecting the expression of T h 2-specific, T h 17-specific or Treg-specific transcription factors (36) . Thus, just as BCL6 and BLIMP1 can function as mutually inhibitory cross-regulators of B cell differentiation pathways (18, 37) , so can they regulate the CD4 T-cell differentiation pathway, amplifying the T FH responses that will then induce strong BCL6-dependent GC reactions. It is interesting that IL-21 is a potent inducer of both BLIMP1 and BCL6 (2), but because of their cross-inhibition, presumably one of these factors will dominate within a particular cell.
T FH cells and IL-21 in autoimmunity
GCs are a critical site for selection of appropriate antibody specificities and T FH cells play an important role in the regulation of autoantibody production, as shown by the systemic autoimmune responses that result from over-expression of T FH signaling proteins such as ICOS or IL-21.
The first suggestion of a connection of IL-21 to autoimmune disease came from the BXSB-Yaa mouse model of systemic lupus erythematosus, which was found to have elevated levels of IL-21 mRNA and serum protein (2) that temporally correlated with development of disease. In this model, IL-21 signaling was shown to be essential to the development of the disease phenotype, as when the BXSB-Yaa mice were crossed onto the Il21r-KO background, there was no hypergammaglobulinemia, autoantibody production or renal disease (38) . Interestingly, these BXSB-Yaa/Il21r-KO mice had greatly reduced numbers of CXCR5 + ICOS + CD4 + T cells, and the excessive IL-21 production did not derive from this population of conventional T FH cells, but rather from an extrafollicular population of ICOS +
CD4
+ T cells (38) . Mice homozygous for the sanroque allele of Roquin also develop a lupus-like disease accompanied by the accumulation of excessive numbers of both GCs and T FH cells with high levels of ICOS and IL-21 expression (39), and lupus-like symptoms were dependent on enhanced GC formation as they could be reduced by deletion of even one allele of the BCL6 (40) . Interestingly, however, T FH formation in this disease may be more dependent on ICOS than IL-21 (40) .
In the MRL lpr mouse, which also develops a lupus-like disease, an extrafollicular population of ICOS hi CD4 + T cells that have down-regulated P-selectin glycoprotein ligand 1 (PSGL-1) were the primary source for IL-21 production and subsequent extrafollicular development of IgG + plasmablasts (41) . These extrafollicular PSGL-1 lo CD4 + cells also occurred at a high frequency in several other autoimmune models. In contrast to the originally defined T FH population, these PSGL-1 lo CD4 + T cells also secreted IL-4 and IFNc, which could instruct appropriate isotype switching in this extrafollicular setting (41) . The relationship between these extrafollicular CD4 + T cells and the T FH population remains to be determined.
It is important to recognize that IL-21 can contribute to other autoimmune diseases as well, ostensibly by B-cellindependent mechanisms. For example, in the non-obese diabetic (NOD) mouse model of type I diabetes, disease no longer develops when the NOD mouse is crossed to the Il21r-KO background (42, 43) . Thus, whereas the relationship of IL-21 to T FH is very important, one must be cognizant that it may not dominate all types of autoimmune responses.
Conclusions
T FH cells are now recognized as a distinct helper subset whose differentiation requires the transcription factor BCL6, leads to a GC-localized population of cells that are critical in the development of a strong Ig response. Naive T FH cells produce abundant IL-21, which then acts as an autocrine factor for the functional activity of these cells. In addition, it is now clear that T FH also have the capacity to produce cytokines characteristic of T h 1, T h 2 and T h 17 cells, emphasizing the developmental and functional plasticity of all these subsets. Future studies are needed to further unravel mechanisms for controlling the production and activation of T FH cells, as these cells and the IL-21 they produce play important roles in a number of systemic autoimmune diseases.
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